Anika Therapeutics, Inc. (ANIK)
NASDAQ·Healthcare·Medical - Devices
$15.42
-2.71%
Mkt Cap $215.74M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $28.88M | $30.61M | +6.03% | -$0.13 | $0.31 | +348.00% | — | — |
| Q4 2025 Nov 5, 2025 | $27.80M | $27.82M | +0.06% | $0.02 | $0.04 | +100.00% | — | — |
| Q3 2025 Jul 30, 2025 | $27.53M | $28.22M | +2.49% | -$0.13 | -$0.13 | +0.00% | — | — |
| Q2 2025 May 9, 2025 | $28.07M | $26.17M | -6.76% | $0.09 | -$0.06 | -166.67% | — | — |
| Q1 2025 Mar 12, 2025 | $28.13M | -$1.29M | -104.59% | -$0.01 | -$0.03 | -200.00% | — | — |
| Q4 2024 Oct 31, 2024 | $29.00M | $38.75M | +33.63% | $0.30 | -$0.25 | -183.33% | — | — |
| Q3 2024 Aug 8, 2024 | $42.10M | $41.92M | -0.43% | $0.23 | $0.17 | -26.09% | — | — |
| Q2 2024 May 8, 2024 | $39.21M | $40.52M | +3.35% | -$0.19 | -$0.31 | -63.16% | — | — |
| Q1 2024 Mar 13, 2024 | $41.40M | $42.97M | +3.79% | -$0.26 | -$4.30 | -1553.85% | — | — |
| Q4 2023 Nov 2, 2023 | $41.40M | $41.47M | +0.16% | -$0.33 | -$0.45 | -36.36% | — | — |
| Q3 2023 Aug 8, 2023 | $40.56M | $44.30M | +9.23% | -$0.34 | -$0.19 | +44.12% | — | — |
| Q2 2023 May 9, 2023 | $37.28M | $37.92M | +1.73% | -$0.36 | -$0.71 | -97.22% | — | — |
| Q1 2023 Mar 6, 2023 | $37.71M | $39.62M | +5.08% | -$0.22 | -$0.34 | -54.55% | — | — |
| Q4 2022 Nov 8, 2022 | $37.59M | $40.26M | +7.12% | -$0.24 | -$0.29 | -20.83% | — | — |
| Q3 2022 Aug 3, 2022 | $37.85M | $39.66M | +4.77% | -$0.26 | -$0.20 | +23.08% | — | — |
| Q2 2022 May 5, 2022 | $32.93M | $36.69M | +11.41% | -$0.31 | -$0.20 | +35.48% | — | — |
| Q1 2022 Mar 8, 2022 | $32.05M | $35.82M | +11.76% | -$0.25 | -$0.40 | -60.00% | — | — |
| Q4 2021 Nov 4, 2021 | $36.65M | $39.54M | +7.87% | -$0.21 | $0.04 | +119.05% | — | — |
| Q3 2021 Aug 5, 2021 | $35.40M | $38.15M | +7.74% | -$0.15 | $0.45 | +400.00% | — | — |
| Q2 2021 May 6, 2021 | $113.16M | $34.29M | -69.70% | -$0.12 | $0.20 | +266.67% | — | — |